ClinicalTrials.govpublic full text
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
anti-mag neuropathy, neuropathy, anti-mag, rituximab, i-rods, placebo, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906364
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.